HCI Group, Inc. (LON:0J22)
London · Delayed Price · Currency is GBP · Price in USD 163.20
+0.17 (0.10%)
At close: Feb 11, 2026
HCI Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Premiums & Annuity Revenue | 748.76 | 682.2 | 500.59 | 467.85 | 381.3 | 265.98 |
Total Interest & Dividend Income | 62.49 | 58.55 | 45.57 | 27.99 | 6.97 | 6.22 |
Gain (Loss) on Sale of Investments | 1.57 | 6.03 | 1.22 | -8.34 | 7.84 | 1.07 |
Other Revenue | 3.76 | 3.27 | 3.29 | 8.95 | 11.81 | 0.2 |
| 816.58 | 750.05 | 550.67 | 496.45 | 407.92 | 273.47 | |
Revenue Growth (YoY) | 8.75% | 36.21% | 10.92% | 21.70% | 49.16% | 12.78% |
Policy Benefits | 300.63 | 374.71 | 254.58 | 371.46 | 227.53 | 160.04 |
Policy Acquisition & Underwriting Costs | 117.2 | 99.4 | 90.82 | 104.98 | 93.73 | 53.86 |
Selling, General & Administrative | 11.71 | 10.79 | 9.99 | 15.11 | 13.75 | 8.13 |
Other Operating Expenses | -1,101 | 25.41 | 21.99 | 24.98 | 21.84 | 13.8 |
Total Operating Expenses | -611.11 | 563.28 | 421.9 | 557.93 | 388.53 | 261.53 |
Operating Income | 1,428 | 186.77 | 128.77 | -61.48 | 19.39 | 11.94 |
Interest Expense | -11.47 | -13.34 | -11.12 | -7.77 | -6.4 | -11.73 |
EBT Excluding Unusual Items | 1,416 | 173.43 | 117.65 | -69.25 | 12.99 | 0.21 |
Asset Writedown | - | - | - | -2.28 | - | - |
Other Unusual Items | -1,125 | - | - | 3.12 | -1.75 | 36.72 |
Pretax Income | 291.22 | 173.43 | 117.65 | -68.42 | 11.23 | 36.93 |
Income Tax Expense | 74.69 | 45.85 | 28.39 | -13.82 | 3.99 | 9.35 |
Earnings From Continuing Ops. | 216.53 | 127.58 | 89.26 | -54.6 | 7.24 | 27.58 |
Minority Interest in Earnings | -12.6 | -17.63 | -10.22 | -3.91 | -5.39 | - |
Net Income | 203.94 | 109.95 | 79.03 | -58.51 | 1.86 | 27.58 |
Preferred Dividends & Other Adjustments | 6.27 | 4.11 | 2.63 | -3.46 | 0.02 | 1.46 |
Net Income to Common | 197.67 | 105.84 | 76.41 | -55.05 | 1.83 | 26.12 |
Net Income Growth | 40.20% | 39.12% | - | - | -93.27% | 3.78% |
Shares Outstanding (Basic) | 12 | 10 | 8 | 9 | 8 | 7 |
Shares Outstanding (Diluted) | 13 | 13 | 11 | 9 | 9 | 10 |
Shares Change (YoY) | 3.87% | 14.87% | 25.26% | 2.76% | -11.49% | -5.31% |
EPS (Basic) | 16.72 | 10.59 | 9.13 | -6.24 | 0.23 | 3.55 |
EPS (Diluted) | 15.80 | 8.89 | 7.62 | -6.24 | 0.21 | 3.49 |
EPS Growth | 32.29% | 16.66% | - | - | -93.98% | 5.45% |
Free Cash Flow | 404.26 | 327.76 | 224.16 | -6.35 | 93.19 | 70.87 |
Free Cash Flow Per Share | 31.49 | 25.84 | 20.30 | -0.72 | 10.86 | 7.31 |
Dividend Per Share | 1.600 | 1.600 | 1.600 | 1.600 | 1.600 | 1.600 |
Operating Margin | 174.84% | 24.90% | 23.38% | -12.38% | 4.75% | 4.37% |
Profit Margin | 24.21% | 14.11% | 13.88% | -11.09% | 0.45% | 9.55% |
Free Cash Flow Margin | 49.51% | 43.70% | 40.71% | -1.28% | 22.84% | 25.92% |
EBITDA | 1,438 | 189.82 | 135.74 | -54.3 | 24.01 | 16.28 |
EBITDA Margin | 176.04% | 25.31% | 24.65% | -10.94% | 5.89% | 5.95% |
D&A For EBITDA | 9.81 | 3.05 | 6.97 | 7.18 | 4.62 | 4.34 |
EBIT | 1,428 | 186.77 | 128.77 | -61.48 | 19.39 | 11.94 |
EBIT Margin | 174.84% | 24.90% | 23.38% | -12.38% | 4.75% | 4.37% |
Effective Tax Rate | 25.65% | 26.43% | 24.13% | - | 35.53% | 25.31% |
Revenue as Reported | 816.58 | 750.05 | 550.67 | 499.56 | 407.92 | 310.44 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.